Navigation Links
TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014
Date:8/18/2014

ORLANDO, Fla., Aug. 18, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is providing a second notice of TNI BioTech's annual meeting of September 4, 2014.

In making the announcement, Noreen Griffin, founder and CEO of TNI BioTech Inc. said, "Thank you in advance for your participation in the Annual Meeting. On behalf of our employees and Board of Directors, I would like to express our appreciation for your continued interest in TNIB.  In addition the Company has received numerous calls from shareholders concerning voting for the annual meeting to be held September 4, 2014.

"If you have received your packet, and will not be able to attend the meeting in person, please mail in your proxy and ballot as soon as possible.  We have received a very limited amount of proxy and ballots via mail to date.

"We have elected to provide access to our proxy materials over the Internet under the Securities and Exchange Commission's 'notice and access' rules. On or about July 22, 2014, we mailed certain of our stockholders a Notice of Internet Availability of Proxy Materials, or Internet Notice, containing instructions on how to access our 2014 proxy statement and annual report and instructions on how to vote online, by telephone or request a paper copy of our proxy materials. Our proxy statement and annual report are available on our website at www.tnibiotech.com/investor-relations/proxy-statements.

"Only stockholders of record at the close of business on July 15, 2014, are entitled to notice of and to vote at the Annual Meeting and at any adjournment or postponement thereof.

"Whether or not you ex
'/>"/>

SOURCE TNI BioTech, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014
2. DanDrit Biotech USA, Inc. Signs Placement Agency Agreement with Sunrise Securities Corp. and Form S-1 Registration Statement Becomes Effective
3. MarketResearch.com: New Biotechnology Market Research Reports Added to Kalorama Information Knowledge Center
4. NCBiotech Names New President and CEO
5. OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
6. Kalorama: Yellen Comments on Biotechnology Sector At Odds With Venture Capital Trends
7. Defining Low Cost in Your Solution for Future Facilities, New Webinar for Pharma, Biotech, Medical Device and Healthcare Companies, Hosted by Xtalks
8. Midwest Biotech Leaders Featured On BioSpace Map
9. The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies
10. Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org
11. Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... New York (PRWEB) December 23, 2014 According ... the Long Island Affiliate of ITRA Global, the national office ... but steady recovery. This is evidenced by the third ... strong stock market. Low energy costs have held inflation ... The only negative is the housing market remaining soft. , ...
(Date:12/24/2014)... The report expects global cell isolation and expansion market ... a carefully analyzed data about the vital drivers, restraints, ... Full Copy of Report @ http://bit.ly/1yUxy0T , ... expansion will keep witnessing growth at an impressive CAGR ... driven by rapid technological advancements, government funding and investments, ...
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... , CANTON, Mass. and SAN DIEGO, Oct. 27 ... speak on the first night of the prestigious TEDMED ... Dr. Bates, speech "Where Does Replacement Skin Come From?" ... of Regenerative Medicine and discuss the transformation of patient ...
... Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), ... company, announced today that its Chief Financial Officer Evan ... at the BIO Investor Forum. , The presentation will ... PM PDT at The Palace Hotel in San Francisco, ...
... , NEW YORK, Oct. 27 How does ... based on invention, innovation and entrepreneurship? , (Logo: ... blogging together with real-time celebrity lectures (and required ... anything other universities have ever attempted. , ...
Cached Biology Technology:Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference 2Soligenix to Present at 8th Annual BIO Investor Forum 2Soligenix to Present at 8th Annual BIO Investor Forum 3Soligenix to Present at 8th Annual BIO Investor Forum 4NYU-Poly Launches Unique Undergrad Forum on Invention, Innovation and Entrepreneurship 2NYU-Poly Launches Unique Undergrad Forum on Invention, Innovation and Entrepreneurship 3NYU-Poly Launches Unique Undergrad Forum on Invention, Innovation and Entrepreneurship 4
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "iPhone 5S Fingerprint Sensor ... report to their offering. ... acquisition of AuthenTec in July 2012, Apple introduced ... It is currently the only device of Apple ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... North America are a growing concern for legislators. Expanded waistlines ... disease and some cancers. One University of Alberta researcher says ... they may find that governments will throw their weight into ... Nola Ries of the Faculty of Law,s Health Law and ...
... a new nanolithography technique that is less expensive than ... with biomedical applications. "Among other things, this type ... use in biological sensors that can identify target molecules, ... medical conditions," says Dr. Albena Ivanisevic, co-author of a ...
... University School of Medicine (BUSM) has shown that a compound ... emphysema and reverse some of the damage caused by the ... cells from patients with emphysema, normal gene activity in altered ... repaired. The study, which is published in BioMed ...
Cached Biology News:Legislated to health? 2Legislated to health? 3Researchers develop new, less expensive nanolithography technique 2BUSM researchers find potential key to halt progression, reverse damage from emphysema 2BUSM researchers find potential key to halt progression, reverse damage from emphysema 3